NDC 68001-347-28 - Decitabine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68001-347
- Requested NDC
- 68001-347-28
- Package NDCs from labels
- 68001-347-28, 68001-347-36
- Manufacturer
- BluePoint Laboratories | Cipla USA Inc. | Cipla Ltd.- Goa
- Effective date
- 2019-03-12
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Decitabine - BluePoint Laboratories | Cipla USA Inc. | Cipla Ltd.- Goa | BluePoint Laboratories | Cipla USA Inc. | Cipla Ltd.- Goa | 2019-03-12 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 68001-347-28 | EA - Each | 68001-347 | 3786c42e-161c-4c8a-9bf3-2d8890b4d18b | 1 | 2018-05-09 |
| 68001-347-36 | EA - Each | 68001-347 | a747e475-95ad-416a-a068-f08444162def | 1 | 2018-05-09 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| POTASSIUM PHOSPHATES | POTASSIUM PHOSPHATE, MONOBASIC POTASSIUM PHOSPHATE, DIBASIC INJECTION, | Amneal Pharmaceuticals Private Limited | 98315c6e-308d-423b-a046-4be1f54d30ae | 2026-09-01 | Warnings, Adverse reactions | 4J9FJ0HL51 |
| POTASSIUM PHOSPHATES | POTASSIUM PHOSPHATE, MONOBASIC POTASSIUM PHOSPHATE, DIBASIC INJECTION, | Amneal Pharmaceuticals Private Limited | 125121b8-bc4c-44ee-906e-e72f652a5aa6 | 2026-09-01 | Warnings, Adverse reactions | 4J9FJ0HL51 |
| Decitabine | DECITABINE | BluePoint Laboratories | 5975fa81-1e29-4d56-e063-6394a90a9cd5 | 2026-08-20 | Warnings, Adverse reactions | 776B62CQ27 |
| Decitabine | DECITABINE | Sagent Pharmaceuticals | 749f8d8c-e378-42a1-b94a-136b606dadb4 | 2026-08-06 | Warnings, Adverse reactions | 776B62CQ27 |
| Potassium Phosphates | POTASSIUM PHOSPHATE, MONOBASIC POTASSIUM PHOSPHATE, DIBASIC | CIVICA, INC. | f7702b2f-d0d1-4696-896d-571607fc0dc8 | 2026-07-10 | Warnings, Adverse reactions | 4J9FJ0HL51 |
| INQOVI | CEDAZURIDINE AND DECITABINE | Taiho Pharmaceutical Co., Ltd. | 91a0f80b-f865-4d06-a40d-4d148d99ee71 | 2026-05-25 | Warnings, Adverse reactions | 776B62CQ27 |
| Decitabine | DECITABINE | Bryant Ranch Prepack | c731a9f0-46ee-41c3-8f89-179cab13bdd2 | 2026-05-06 | Warnings, Adverse reactions | 776B62CQ27 |
| Dibasic Sodium Phosphate, Monobasic Potassium Phosphate and Monobasic Sodium Phosphate | DIBASIC SODIUM PHOSPHATE, MONOBASIC POTASSIUM PHOSPHATE AND MONOBASIC SODIUM PHOSPHATE | Rising Pharma Holdings, Inc. | b01eac95-dbe3-4b21-a922-187e0fc8ad23 | 2026-04-07 | Adverse reactions | 4J9FJ0HL51 |
| Decitabine | DECITABINE | Dr. Reddy's Laboratories Inc. | 358764ca-4c69-d516-af0c-bf8a348d26ca | 2026-03-25 | Warnings, Adverse reactions | 776B62CQ27 |
| Decitabine | DECITABINE | Dr.Reddy's Laboratories Limited | 4e1f4eb4-19b2-eee8-3402-bd2ccf622791 | 2026-03-25 | Warnings, Adverse reactions | 776B62CQ27 |
| PHOSPHA 250 NEUTRAL | DIBASIC SODIUM PHOSPHATE, MONOBASIC POTASSIUM PHOSPHATE AND MONOBASIC SODIUM PHOSPHATE | Rising Pharma Holdings, Inc. | 9432adfc-6add-4ab4-ae93-2e2daf348be2 | 2026-03-25 | Adverse reactions | 4J9FJ0HL51 |
| POTASSIUM PHOSPHATES | POTASSIUM PHOSPHATES | GLENMARK PHARMACEUTICALS INC., USA | 70c7710c-a354-4941-bd46-e64d6ea6b5dc | 2026-03-20 | Warnings, Adverse reactions | 4J9FJ0HL51 |
| Decitabine | DECITABINE | Meitheal Pharmaceuticals Inc. | a535a235-e1d2-4520-93fe-b7dd9b047784 | 2025-12-15 | Warnings, Adverse reactions | 776B62CQ27 |
| Helleborus comp. A | HELLEBORUS COMP. A | Uriel Pharmacy Inc. | 150e57ad-3ed7-5cc9-e063-6394a90a25fe | 2025-11-21 | Warnings | 4J9FJ0HL51 |
| Ionosol MB and Dextrose | DEXTROSE MONOHYDRATE, SODIUM LACTATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, POTASSIUM PHOSPHATE, MONOBASIC, AND SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | ICU Medical Inc. | 1b457b1d-0e80-4578-ba6f-dedf513fc962 | 2025-10-30 | Warnings, Adverse reactions | 4J9FJ0HL51 |
| Potassium Phosphates | POTASSIUM PHOSPHATES | Hospira, Inc. | 2fcbc814-c7a4-469a-8b1d-6819b961bfb9 | 2025-09-30 | Warnings, Adverse reactions | 4J9FJ0HL51 |
| Decitabine | DECITABINE | BluePoint Laboratories | de303068-589e-4e0a-90ed-e60b2c1a2b56 | 2025-09-29 | Warnings, Adverse reactions | 776B62CQ27 |
| POTASSIUM PHOSPHATES | POTASSIUM PHOSPHATES IN SODIUM CHLORIDE | Amneal Pharmaceuticals LLC | dce22c93-aa48-48a9-ac8b-716400d33c9e | 2025-09-01 | Warnings, Adverse reactions | 4J9FJ0HL51 |
| Decitabine | DECITABINE | BluePoint Laboratories | 00caa305-fef4-471b-b9c3-4bcf5fe7b244 | 2025-08-05 | Warnings, Adverse reactions | 776B62CQ27 |
| Decitabine | DECITABINE | Meitheal Pharmaceuticals Inc. | a3771445-1c68-4883-a014-74f8793f3136 | 2025-07-23 | Warnings, Adverse reactions | 776B62CQ27 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.